AMAG Pharmaceuticals, Inc. (AMAG) Misses Q4 EPS by 10c; Reaffirms FY13 Rev Outlook
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q4 EPS of ($0.17), $0.10 worse than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
